PLoS ONE (Jan 2017)

Functional paralysis of GM-CSF-derived bone marrow cells productively infected with ectromelia virus.

  • Lidia Szulc-Dąbrowska,
  • Justyna Struzik,
  • Agnieszka Ostrowska,
  • Maciej Guzera,
  • Felix N Toka,
  • Magdalena Bossowska-Nowicka,
  • Małgorzata M Gieryńska,
  • Anna Winnicka,
  • Zuzanna Nowak,
  • Marek G Niemiałtowski

DOI
https://doi.org/10.1371/journal.pone.0179166
Journal volume & issue
Vol. 12, no. 6
p. e0179166

Abstract

Read online

Ectromelia virus (ECTV) is an orthopoxvirus responsible for mousepox, a lethal disease of certain strains of mice that is similar to smallpox in humans, caused by variola virus (VARV). ECTV, similar to VARV, exhibits a narrow host range and has co-evolved with its natural host. Consequently, ECTV employs sophisticated and host-specific strategies to control the immune cells that are important for induction of antiviral immune response. In the present study we investigated the influence of ECTV infection on immune functions of murine GM-CSF-derived bone marrow cells (GM-BM), comprised of conventional dendritic cells (cDCs) and macrophages. Our results showed for the first time that ECTV is able to replicate productively in GM-BM and severely impaired their innate and adaptive immune functions. Infected GM-BM exhibited dramatic changes in morphology and increased apoptosis during the late stages of infection. Moreover, GM-BM cells were unable to uptake and process antigen, reach full maturity and mount a proinflammatory response. Inhibition of cytokine/chemokine response may result from the alteration of nuclear translocation of NF-κB, IRF3 and IRF7 transcription factors and down-regulation of many genes involved in TLR, RLR, NLR and type I IFN signaling pathways. Consequently, GM-BM show inability to stimulate proliferation of purified allogeneic CD4+ T cells in a primary mixed leukocyte reaction (MLR). Taken together, our data clearly indicate that ECTV induces immunosuppressive mechanisms in GM-BM leading to their functional paralysis, thus compromising their ability to initiate downstream T-cell activation events.